Literature DB >> 23787166

Prognostic marker for patients with malignant ureter obstruction.

Takeshi Azuma1, Yasushi Nagase, Masaya Oshi.   

Abstract

PURPOSE: To investigate the relationship between overall survival (OS) and prognostic risk factors for patients with malignant ureteral obstruction. PATIENTS AND METHODS: We retrospectively evaluated 214 patients who had received a nephrostomy for ureteral obstruction because of malignancy. Univariate and multivariate Cox regression models addressed OS.
RESULTS: The median OS was 6.4 months. The OS at 1, 3, 6, and 12 months were 89.5%, 72.4%, 53.0%, and 26.5%, respectively. Using univariate Cox regression analysis, serum levels of creatinine (P = .0131), albumin (P < .0001), sodium (P < .0001), potassium (P = .0141), corrected calcium (P = .0167), C-reactive protein (P < .0001), white blood cell count (P = .0246), and the number of events related to malignant dissemination (P < .0001) were associated with OS. Using multivariate Cox regression analysis, serum levels of albumin (P = .0147), sodium (P = .0046), C-reactive protein (P < .0001), and the number of events related to malignant dissemination (P = .0002) were independent predictors of OS.
CONCLUSION: Low serum levels of albumin and sodium and the number of events related to malignant dissemination before PCN were independent factors associated with a poor prognosis. High serum C-reactive protein level was also associated with a poor prognosis using multivariate analysis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Hydronephrosis; Percutaneous nephrostomy; Prognosis factor

Mesh:

Substances:

Year:  2013        PMID: 23787166     DOI: 10.1016/j.clgc.2013.04.030

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  3 in total

Review 1.  Malignant ureteric obstruction decompression: how much gain for how much pain? A narrative review.

Authors:  Joanna Prentice; Tarik Amer; Ali Tasleem; Omar Aboumarzouk
Journal:  J R Soc Med       Date:  2018-04       Impact factor: 5.344

2.  A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study.

Authors:  Kouji Izumi; Takashi Shima; Kazuyoshi Shigehara; Kiyoshi Sawada; Renato Naito; Yuki Kato; Mitsuo Ofude; Hiroshi Kano; Hiroaki Iwamoto; Hiroshi Yaegashi; Kazufumi Nakashima; Masashi Iijima; Shohei Kawaguchi; Takahiro Nohara; Yoshifumi Kadono; Atsushi Mizokami
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

Review 3.  Stents for malignant ureteral obstruction.

Authors:  Kristina Pavlovic; Dirk Lange; Ben H Chew
Journal:  Asian J Urol       Date:  2016-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.